Cancer immunology and immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
| Τόπος έκδοσης: | Springer eBooK. |
|---|---|
| Συγγραφή απο Οργανισμό/Αρχή: | |
| Άλλοι συγγραφείς: | |
| Μορφή: | Electronic Resource |
| Γλώσσα: | English |
| Έκδοση: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2011
|
| Σειρά: | Issues in children's and families' lives
no.2 |
| Θέματα: | |
| Διαθέσιμο Online: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |